Table: begin end state 1 13 non-cytoplasmic 14 33 transmembrane 34 38 cytoplasmic 39 58 transmembrane 59 123 non-cytoplasmic 124 144 transmembrane 145 164 cytoplasmic 165 189 transmembrane 190 196 non-cytoplasmic 197 217 transmembrane 218 226 cytoplasmic 227 249 transmembrane 250 260 non-cytoplasmic 261 282 transmembrane 283 290 cytoplasmic 291 311 transmembrane 312 330 non-cytoplasmic 331 350 transmembrane 351 369 cytoplasmic 370 391 transmembrane 392 470 non-cytoplasmic 471 491 transmembrane 492 515 cytoplasmic 516 535 transmembrane 536 546 non-cytoplasmic 547 572 transmembrane 573 578 cytoplasmic 579 600 transmembrane 601 644 non-cytoplasmic 645 667 transmembrane 668 691 cytoplasmic
Input: >N515DRAFT_4411 FitnessBrowser__Dyella79:N515DRAFT_4411 MHTAVTKPSPAGKILWAAIAIVGAWCLGVVALRRGEPINAIWLVAAAIAVFVIGYRFYSR FIDTYVLRMDPSRATPAVLRNDGLDYVPTDKWVVFGHHFAAIAGAGPLVGPVLAAQMGYL PGTLWILFGVVFAGAVQDFMILGLSVRRDGRSLGNMLRDELGPVAGIVAMFGVLVLMMIV LAVLALVVVKALTHSPWGTYTVACTIPIALLMGIYLRYIRPGKILEVSIVGLILLLLAIW SGAYVAASPAWAAAFDFDAKALAWLLIAYGFCASVLPVWLLLAPRDYLSTFLKIGTIALL ALAIFLAAPTLQMPALTKFVDGTGPVFQGNLFPFLFITIACGAVSGWHSIISSGTTPKLL SNEGEARMVGYGGMLMEAFVAIMALIAAASMHPGVYFAMNSPAALIGTTAQSAATAISQW GFVVSPDELLNTARNIGESSILSRAGGAPTLAVGMAQLLHGIIPGEGMMAFWYHYAILFE ALFILTTVDAGTRVGRFMIQEIAGLIHEPLKHTESWTGNLIATAICVGLWGYFLYQGAVD PLGGINTLWPLFGIANQMLAAVALMLATVVTVKLKRERYVWVPGIPAIWLVVCTLTAGYY KLVGSISFTAAAQKYAAAAAEGKLLAPAKSVAEMQRIVTNNYVDAALTGIFMLLVVTMAG FAINAILKAWRVNHPTAHEEPYVALEGAPTR
Or try the official Phobius web server, which has a different display
Reference: Advantages of combined transmembrane topology and signal peptide prediction - the Phobius web server